DJO Incorporated's Pending Merger with ReAble Therapeutics Clears U.S. Antitrust Review
2007年8月16日 - 8:55PM
ビジネスワイヤ(英語)
DJO Incorporated (NYSE:DJO), a global provider of products and
services that promote musculoskeletal and vascular health, today
reported that on August 9, 2007, the U.S. Federal Trade Commission
(�FTC�) granted early termination of the waiting period under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,
for the proposed acquisition of DJO by an affiliate of ReAble
Therapeutics, Inc. (�ReAble�). On July 16, 2007, DJO announced that
it had entered into an agreement and plan of merger under which an
affiliate of ReAble will acquire all outstanding shares of DJO�s
common stock for a cash payment of $50.25 per share. An affiliate
of The Blackstone Group (�Blackstone�) is the controlling
shareholder of ReAble. On July 27, 2007, DJO and Blackstone
submitted pre-merger notification and report forms with the FTC and
the United States Department of Justice, Antitrust Division. The
granting of early termination of the waiting period means the
proposed acquisition has cleared U.S. antitrust review, but remains
subject to satisfaction of several other conditions, including
approval of the transaction by DJO's stockholders and the
expiration or termination of the waiting period under the German
Act Against Restraints of Competition. Additional Information and
Where to Find It In connection with the proposed transaction, DJO
intends to file a proxy statement with the Securities and Exchange
Commission (the �SEC�). STOCKHOLDERS ARE URGED TO READ THE PROXY
STATEMENT (AND ALL AMENDMENTS AND SUPPLEMENTS TO IT) AND OTHER
MATERIALS THAT THE COMPANY MAY FILE WITH THE SEC IN THEIR ENTIRETY
WHEN SUCH MATERIALS BECOME AVAILABLE, BECAUSE THE MATERIALS WILL
CONTAIN IMPORTANT INFORMATION ABOUT DJO AND THE PROPOSED
TRANSACTION. The final proxy statement will be mailed to the
Company�s stockholders. Stockholders will be able to obtain free
copies of the final proxy statement, as well as the Company�s other
filings, without charge, at the SEC�s Web site (www.sec.gov) when
they become available. Copies of the filings may also be obtained
without charge from the Company by directing a request to: DJO
Incorporated, 1430 Decision Street, Vista, CA, 92081, Attention:
Mark Francois, Director of Investor Relations (Tel: 1-760-734-4766,
Email: mark.francois@djortho.com). Participants in the Solicitation
DJO and its directors, executive officers and other members of
management and employees may be deemed to be participants in the
solicitation of proxies from stockholders in respect of the
proposed transaction. Information regarding DJO�s directors and
executive officers is available in the Company�s 2006 Annual Report
on Form 10-K, filed with the SEC on March 1, 2007 and the Company�s
proxy statement for its 2007 annual meeting of stockholders, filed
with the SEC on April 20, 2007. Additional information regarding
the interests of such potential participants will be included in
the proxy statement filed with the SEC in connection with the
Special Meeting of Stockholders when it becomes available. Safe
Harbor Statement This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Such statements include statements about the conduct of DJO and
ReAble following this announcement and the anticipated timing of
the transaction. The words �believe,� �should,� �expect,� �intend,�
�estimate� and �anticipate,� variations of such words and similar
expressions identify forward-looking statements, but their absence
does not mean that a statement is not a forward-looking statement.
These forward-looking statements are based on DJO�s and ReAble�s
current expectations and are subject to a number of risks,
uncertainties and assumptions. The Company undertakes no obligation
to update any forward-looking statements, whether as a result of
new information, future events or otherwise. The important factors
that could cause actual results to differ significantly from those
expressed or implied by such forward-looking statements include,
but are not limited to, the occurrence of any event, change or
other circumstance that could give rise to a termination of the
merger agreement; the outcome of any legal proceedings that may be
instituted against DJO, ReAble or others following the announcement
of the merger agreement the inability to complete the merger due to
the failure to obtain stockholder approval or the failure to
satisfy other conditions to the merger, including receiving
applicable foreign regulatory approvals relating to the
transaction; the failure to obtain the necessary financing
arrangements set forth in the commitment letters received in
connection with the merger; risks that the proposed transaction
disrupts current plans and operations and the potential
difficulties in employee retention as a result of the merger. Other
risk factors are detailed in the Company�s Quarterly Report on Form
10-Q for the three months ended June 30, 2007, filed on August 3,
2007, with the Securities and Exchange Commission and ReAble�s
Quarterly Report on Form 10-Q for the three months ended June 30,
2007, filed on August 14, 2007, with the Securities and Exchange
Commission. Many of the factors that will determine the outcome of
the subject matter of this press release are beyond DJO�s and
ReAble�s ability to control or predict.
DJ Orthopedics (NYSE:DJO)
過去 株価チャート
から 5 2024 まで 6 2024
DJ Orthopedics (NYSE:DJO)
過去 株価チャート
から 6 2023 まで 6 2024